November 17, 2026 at 09:54 PM UTC
Aldeyra Therapeutics, Inc. reports listing or compliance development
Aldeyra Therapeutics, Inc. filed an 8-K covering a listing or compliance notice. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 17, 2026 at 09:50 PM UTC
Open official source